Literature DB >> 28404596

Tumor Necrosis Factor-α Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle.

Margaret Chui Ling Tse1, Oana Herlea-Pana2, Daniel Brobst2, Xiuying Yang2,3, John Wood2, Xiang Hu2, Zhixue Liu2, Chi Wai Lee1, Aung Moe Zaw4, Billy K C Chow4, Keqiang Ye5, Chi Bun Chan6.   

Abstract

Tumor necrosis factor-α (TNF-α) is an inflammatory cytokine that plays a central role in obesity-induced insulin resistance. It also controls cellular lipid metabolism, but the underlining mechanism is poorly understood. We report in this study that phosphoinositide 3-kinase enhancer A (PIKE-A) is a novel effector of TNF-α to facilitate its metabolic modulation in the skeletal muscle. Depletion of PIKE-A in C2C12 myotubes diminished the inhibitory activities of TNF-α on mitochondrial respiration and lipid oxidation, whereas PIKE-A overexpression exacerbated these cellular responses. We also found that TNF-α promoted the interaction between PIKE-A and AMP-activated protein kinase (AMPK) to suppress its kinase activity in vitro and in vivo. As a result, animals with PIKE ablation in the skeletal muscle per se display an upregulation of AMPK phosphorylation and a higher preference to use lipid as the energy production substrate under high-fat diet feeding, which mitigates the development of diet-induced hyperlipidemia, ectopic lipid accumulation, and muscle insulin resistance. Hence, our data reveal PIKE-A as a new signaling factor that is important for TNF-α-initiated metabolic changes in skeletal muscle.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28404596      PMCID: PMC5482076          DOI: 10.2337/db16-0270

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  48 in total

1.  Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex.

Authors:  Chi Bun Chan; Xia Liu; Sompol Pradoldej; Chunhai Hao; Jie An; Manuel Yepes; Hongbo R Luo; Keqiang Ye
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity.

Authors:  S Zhang; Q Qi; C B Chan; W Zhou; J Chen; H R Luo; C Appin; D J Brat; K Ye
Journal:  Cell Death Differ       Date:  2015-05-22       Impact factor: 15.828

Review 3.  Cytohesins and centaurins: mediators of PI 3-kinase-regulated Arf signaling.

Authors:  T R Jackson; B G Kearns; A B Theibert
Journal:  Trends Biochem Sci       Date:  2000-10       Impact factor: 13.807

4.  Effects of AMPK activation on insulin sensitivity and metabolism in leptin-deficient ob/ob mice.

Authors:  Robby Zachariah Tom; Pablo M Garcia-Roves; Rasmus J O Sjögren; Lake Q Jiang; Maria H Holmström; Atul S Deshmukh; Elaine Vieira; Alexander V Chibalin; Marie Björnholm; Juleen R Zierath
Journal:  Diabetes       Date:  2014-01-31       Impact factor: 9.461

5.  SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice.

Authors:  B Emanuelli; P Peraldi; C Filloux; C Chavey; K Freidinger; D J Hilton; G S Hotamisligil; E Van Obberghen
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

6.  PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt.

Authors:  Jee-Yin Ahn; Yuanxin Hu; Todd G Kroll; Paulette Allard; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

7.  PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development.

Authors:  Chi-Bun Chan; Xia Liu; Michael A Ensslin; Dirck L Dillehay; Christopher J Ormandy; Philip Sohn; Rosa Serra; Keqiang Ye
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

8.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

9.  Short-term effects of tumor necrosis factor on energy and substrate metabolism in dogs.

Authors:  Y Sakurai; X U Zhang; R R Wolfe
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Fas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance.

Authors:  Stephan Wueest; Rouven Mueller; Matthias Blüher; Flurin Item; Annie S H Chin; Michael S F Wiedemann; Hitoshi Takizawa; Larisa Kovtonyuk; Alexander V Chervonsky; Eugen J Schoenle; Markus G Manz; Daniel Konrad
Journal:  EMBO Mol Med       Date:  2014-01       Impact factor: 12.137

View more
  9 in total

Review 1.  Control strategies in systemic metabolism.

Authors:  Jessica Ye; Ruslan Medzhitov
Journal:  Nat Metab       Date:  2019-10-07

2.  Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.

Authors:  Linlin Shao; Zheng Chen; Mohammed Soutto; Shoumin Zhu; Heng Lu; Judith Romero-Gallo; Richard Peek; Shutian Zhang; Wael El-Rifai
Journal:  FASEB J       Date:  2018-07-09       Impact factor: 5.191

Review 3.  Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitus.

Authors:  Jing Li; Yazhuo Chen; Qingyun Liu; Zhufang Tian; Yan Zhang
Journal:  Clin Exp Med       Date:  2022-03-20       Impact factor: 3.984

4.  Long intergenic non-protein coding RNA 00475 silencing acts as a tumor suppressor in glioma under hypoxic condition by impairing microRNA-449b-5p-dependent AGAP2 up-regulation.

Authors:  Lei Yu; Si Gui; Yawei Liu; Xiaoyu Qiu; Binghui Qiu; Xi'an Zhang; Jun Pan; Jun Fan; Songtao Qi; Guozhong Zhang
Journal:  Ther Adv Med Oncol       Date:  2020-08-11       Impact factor: 8.168

Review 5.  Impacts of Selected Dietary Nutrient Intakes on Skeletal Muscle Insulin Sensitivity and Applications to Early Prevention of Type 2 Diabetes.

Authors:  Xin Zhang; Doudou Xu; Meixia Chen; Yubo Wang; Linjuan He; Lu Wang; Jiangwei Wu; Jingdong Yin
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

6.  Emerging pathways of communication between the heart and non-cardiac organs.

Authors:  Eugenio Hardy-Rando; Carlos Fernandez-Patron
Journal:  J Biomed Res       Date:  2019-06-04

7.  Deficiency of fibroblast growth factor 21 aggravates obesity-induced atrophic responses in skeletal muscle.

Authors:  Chu-Sook Kim; Yeonsoo Joe; Hye-Seon Choi; Sung Hoon Back; Jeong Woo Park; Hun Taeg Chung; Eun Roh; Min-Seon Kim; Tae Youl Ha; Rina Yu
Journal:  J Inflamm (Lond)       Date:  2019-07-04       Impact factor: 4.981

8.  Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis.

Authors:  Olivia Patsalos; Bethan Dalton; Jenni Leppanen; Mohammad A A Ibrahim; Hubertus Himmerich
Journal:  Front Pharmacol       Date:  2020-04-15       Impact factor: 5.810

9.  Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis.

Authors:  Eugenio Hardy; Carlos Fernandez-Patron
Journal:  Biomolecules       Date:  2021-03-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.